[HTML][HTML] Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter study
WC Fan, CJ Yu, CM Tsai, MS Huang, CL Lai… - Journal of Thoracic …, 2011 - Elsevier
Introduction: Epidermal growth factor receptor-tyrosine kinase inhibitors are used as
effective first-line and salvage therapy in the treatment of advanced non-small cell lung …
effective first-line and salvage therapy in the treatment of advanced non-small cell lung …
Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter study.
WC Fan, CJ Yu, CM Tsai, MS Huang… - Journal of Thoracic …, 2011 - europepmc.org
Methods Clinical data of NSCLC patients treated with gefitinib or erlotinib from January 2004
to December 2008 were collected retrospectively. Five tertiary referral centers in Taiwan …
to December 2008 were collected retrospectively. Five tertiary referral centers in Taiwan …
Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Multicenter Study
WC Fan, CJ Yu, CM Tsai, MS Huang, CL Lai… - Journal of Thoracic …, 2011 - jto.org
Introduction: Epidermal growth factor receptor-tyrosine kinase inhibitors are used as
effective first-line and salvage therapy in the treatment of advanced non-small cell lung …
effective first-line and salvage therapy in the treatment of advanced non-small cell lung …
[PDF][PDF] Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer
WC Fan, CJ Yu, CM Tsai, MS Huang… - Journal of Thoracic …, 2011 - scholar.archive.org
Methods: Clinical data of NSCLC patients treated with gefitinib or erlotinib from January
2004 to December 2008 were collected retrospectively. Five tertiary referral centers in …
2004 to December 2008 were collected retrospectively. Five tertiary referral centers in …
Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter study
WC Fan, CJ Yu, CM Tsai, MS Huang… - Journal of thoracic …, 2011 - pubmed.ncbi.nlm.nih.gov
Introduction Epidermal growth factor receptor-tyrosine kinase inhibitors are used as effective
first-line and salvage therapy in the treatment of advanced non-small cell lung cancer …
first-line and salvage therapy in the treatment of advanced non-small cell lung cancer …
Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-Small Cell Lung Cancer a Retrospective Multicenter Study
WC Fan, CJ Yu, CM Tsai, MS Huang… - JOURNAL OF …, 2011 - ntur.lib.ntu.edu.tw
Introduction: Epidermal growth factor receptor-tyrosine kinase inhibitors are used as
effective first-line and salvage therapy in the treatment of advanced non-small cell lung …
effective first-line and salvage therapy in the treatment of advanced non-small cell lung …
[PDF][PDF] Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer
WC Fan, CJ Yu, CM Tsai, MS Huang, CL Lai… - Journal of Thoracic …, 2011 - core.ac.uk
Methods: Clinical data of NSCLC patients treated with gefitinib or erlotinib from January
2004 to December 2008 were collected retrospectively. Five tertiary referral centers in …
2004 to December 2008 were collected retrospectively. Five tertiary referral centers in …
[PDF][PDF] Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer
WC Fan, CJ Yu, CM Tsai, MS Huang, CL Lai… - Journal of Thoracic …, 2011 - academia.edu
Methods: Clinical data of NSCLC patients treated with gefitinib or erlotinib from January
2004 to December 2008 were collected retrospectively. Five tertiary referral centers in …
2004 to December 2008 were collected retrospectively. Five tertiary referral centers in …